[Federal Register Volume 71, Number 235 (Thursday, December 7, 2006)]
[Notices]
[Pages 70973-70974]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-9577]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2) notice

[[Page 70974]]

is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The purpose of this meeting is to evaluate 
proposals for support through the RAID program by making available to 
the research community, on a competitive basis, NCI new agent 
development contract resources for the preclinical development of drugs 
and biologics. The outcome of the evaluation will be a decision whether 
NCI should support the request and make available contract resources 
for support through the RAID program to the research community, NCI new 
agent development for the preclinical development of drugs and 
biologics. The research proposals and the discussions could disclose 
confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the proposed research projects, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Rapid Access to Intervention Development.
    Date: December 20, 2006.
    Time: 8:30 a.m.-5 p.m.
    Agenda: To evaluate Rapid Access to Intervention Development 
Portfolio.
    Place: National Institutes of Health, 6130 Executive Boulevard, 
Rm. 319, Rockville, MD 20852.
    Contact Person: Phyllis G. Bryant, Executive Secretary, Program 
Analyst, Developmental Therapeutics Program, National Cancer 
Institute, NIH, 6130 Executive Boulevard, Rm. 8022, Bethesda, MD 
20892, 301 435-9137.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: November 30, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-9577 Filed 12-6-06; 8:45 am]
BILLING CODE 4140-01-M